Opus Genetics, Inc. (IRD)

CIK 1228627 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Opus Genetics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202640001140361-26-042102
Nov 3, 20261440001974078-26-000396
Oct 27, 202640001140361-26-040908
Oct 27, 202640001140361-26-040893
Oct 27, 2026SCHEDULE 13G0002012383-26-003823
Oct 27, 202640001140361-26-040906
Oct 27, 202640001140361-26-040896
Oct 23, 20261440001974158-26-000110
Oct 23, 20261440001974078-26-000387
Oct 23, 20261440001974078-26-000385
Oct 21, 20268-K0001140361-26-040377
Oct 15, 20268-K0001140361-26-039781
Oct 2, 202640002042266-26-000002
Sep 11, 20268-K0001140361-26-036277
Sep 11, 202640001140361-26-036347
Sep 9, 20268-K0001140361-26-035979
Sep 8, 202640001140361-26-035912
Sep 8, 202640001140361-26-035913
Sep 3, 20261440001974158-26-000100
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000020
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003425
Aug 14, 2026EFFECT9999999995-26-002668
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352641
Aug 7, 2026S-30001140361-26-031740
Aug 6, 20268-K0001628280-26-053824